Dr. John C. Canzano, MD

Dr. Canzano practices at Zeiter Eye Surgical Center, Inc. in Stockton, California.

Dr. Canzano's NPI, 1134232648, was assigned on August 17, 2006. Dr. Canzano graduated from Emory School of Medicine in 1994. Dr. Canzano holds California license A55787.

Dr. Canzano's primary practice is Zeiter Eye Surgical Center, Inc., at 1801 E March Ln, Stockton, CA 95210 in San Joaquin County. The practice phone is (209) 337-2020.

Dr. Canzano's primary practice is Zeiter Eye Surgical Center, Inc. in Stockton, California. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Canzano to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Canzano practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Canzano's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Canzano is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Canzano is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Canzano treats.

CMS data shows 56,251 Medicare services from Dr. Canzano across 23 procedure codes in 2024, for 1,806 Medicare patients. Medicare paid $1,828,436 for them.

CMS counts 1,806 Medicare patients who saw Dr. Canzano in 2024. The largest group is 75 to 84, with 782 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Canzano's median patient age at 71, with 57% women.

In 2024, Dr. Canzano wrote 3,052 Medicare Part D claims for 1,182 patients. 39% of them were for generic drugs. CMS names the drug for 2,949 of them, across 21 drugs with 11 or more claims each, at $305,137 in total drug cost. In 2023, CMS named 2,726 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Canzano for performance year 2024, reported as part of a group. Dr. Canzano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 845 procedures of cataract surgery by Dr. Canzano, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Canzano. The most frequent topics are AIDS-Related Opportunistic Infections, CD4 Lymphocyte Count and Cytomegalovirus Retinitis. Dr. Canzano has published most often in Retina. Dr. Canzano's most frequent co-author is Robert Thomas Wendel, MD.

CMS Open Payments shows 192 general payments to Dr. Canzano from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Alcon Laboratories Inc paid the most, $1,434.

Dmand AI lists 2 awards for Dr. Canzano, most recently CMS Stage 1 EHR in 2013.

Dr. Canzano graduated from Emory School of Medicine in 1994. Dr. Canzano is a member of AAO.

Dr. Canzano is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.